While multiple signaling pathways are implicated in the regulation of vasculogenesis, angiogenesis, and remodeling of the vessel wall, the vascular endothelial-derived growth factor (VEGF)-A pathway plays essential roles during development and physiological homeostasis. VEGF-A, the main focus of this chapter, belongs to a gene family that also includes VEGF-B, VEGF-C, VEGF-D, and placenta growth factor (PlGF). Two tyrosine kinases, VEGFR1 and VEGFR2, bind VEGF-A, but VEGFR2 is the main signaling receptor. The key role of VEGF-A in the pathogenesis of cancers and blinding ocular diseases has been established over the past two decades. Elucidation of the molecular and biological properties of VEGF-A led to major advances in cancer therapy and to the first effective treatment for neovascular age-related macular degeneration.
CITATION STYLE
Ferrara, N. (2019). The role of the VEGF signaling pathway in tumor angiogenesis. In Tumor Angiogenesis: A Key Target for Cancer Therapy (pp. 211–226). Springer International Publishing. https://doi.org/10.1007/978-3-319-33673-2_3
Mendeley helps you to discover research relevant for your work.